Skip To Main Content

Kristine Ashcraft, Chief Operating Officer of Genelex to speak at ONU

Kristine Ashcraft will be the guest speaker at the October meeting of the Student Personalized Medicine Coalition/College of Pharmacy.
The meeting will be held in HPPEC151 at 6:00 PM on October 11th.
Kristine is the Cheif Operating Officer of Genelex Corporation of Seattle, WA. Genelex is a privately held corporation providing comprehensive DNA testing services designed to enhance the health and safety of society. Originally founded as a paternity and forensics lab, Genelex started providing pharmacogenetic testing in 2000. The company provide decision support tools ("YouScript") for healthcare providers. YouScript includes testing, patented software, and clinical pharmacist support to provide a turnkey solution for healthcare providers wanting safer and more effective medication management for their patients.
If a scientific advancement remains unknown, unavailable or too costly, it will improve few lives. Kristine passionately believes that, and she works tirelessly to bring Genelex’s advancements to the widest possible audience.

Kristine joined Genelex in 2000 as director of sales and marketing. Kristine, a molecular biologist by training, claims more than 15 years of sales and marketing management experience, including more than a decade at Genelex bringing genetic technologies to market. She is responsible for operations, sales strategy, business development and marketing implementation at the company.

Kristine holds an MBA from Babson College, Magna Cum Laude, and a Bachelor of Science in biology from the University of New Haven.